Omega Pharma Sale Said to Attract Perrigo and Boehringer

Omega Pharma NV, the Belgian over-the-counter health-care company, has attracted interest from companies including Perrigo Co. and Germany’s Boehringer Ingelheim GmbH, according to people familiar with the matter.

Bayer AG and Sanofi may also join other bidders looking at Nazareth, Belgium-based Omega Pharma, the people said, asking not to be identified because the process is private. The sale, which is still in early stages, could fetch more than 4 billion euros ($5.3 billion), the people said. Omega Pharma is working with Morgan Stanley, Bloomberg News reported last month.